Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
17.70
+0.08 (0.45%)
At close: Oct 22, 2024, 4:00 PM
17.93
+0.23 (1.30%)
After-hours: Oct 22, 2024, 7:52 PM EDT
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $1.61 billion as of October 23, 2024. Its market cap has increased by 5.18% in one year.
Market Cap
1.61B
Enterprise Value
1.36B
1-Year Change
5.18%
Ranking
Category
Stock Price
$17.70
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $1.61B, an increase of 1,590.41%. That is a compound annual growth rate of 33.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2024 | 1.60B | -40.68% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
| Feb 18, 2015 | 95.30M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.67B |
| BioCryst Pharmaceuticals | 1.64B |
| Syndax Pharmaceuticals | 1.63B |
| ARS Pharmaceuticals | 1.63B |
| Novavax | 1.62B |
| Fortrea Holdings | 1.59B |
| GeneDx Holdings | 1.56B |
| InMode | 1.55B |